Botox producer sees Irish profits rise 80%

THE main Irish subsidiary of Allergan, the producers of Botox, last year increased its pre-tax profits by 80% to $87m (€59m).

In accounts just filed by Allergan Pharmaceuticals Holdings (Ireland) Ltd to the Companies’ Office, they show that the holding company increased its turnover by 30% from $283.5m to $369.3m to the end of December last.

The US-owned Allergan employs 840 people in Ireland with 780 people employed at its main 500,000sq ft manufacturing plant on a 30-acre campus at Westport, Co Mayo, where Botox is one of a number of pharmaceutical products made.